These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 20852631)

  • 41. BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype.
    Santarosa M; Maestro R
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):131-42. PubMed ID: 22101651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.
    Vaziri SA; Krumroy LM; Elson P; Budd GT; Darlington G; Myles J; Tubbs RR; Casey G
    Clin Cancer Res; 2001 Jul; 7(7):1937-45. PubMed ID: 11448907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
    Evans DG; Brentnall A; Byers H; Harkness E; Stavrinos P; Howell A; ; Newman WG; Cuzick J
    J Med Genet; 2017 Feb; 54(2):111-113. PubMed ID: 27794048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 11q13 is a susceptibility locus for hormone receptor positive breast cancer.
    Lambrechts D; Truong T; Justenhoven C; Humphreys MK; Wang J; Hopper JL; Dite GS; Apicella C; Southey MC; Schmidt MK; Broeks A; Cornelissen S; van Hien R; Sawyer E; Tomlinson I; Kerin M; Miller N; Milne RL; Zamora MP; Pérez JI; Benítez J; Hamann U; Ko YD; Brüning T; ; Chang-Claude J; Eilber U; Hein R; Nickels S; Flesch-Janys D; Wang-Gohrke S; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Chenevix-Trench G; Beesley J; Chen X; ; ; Menegaux F; Cordina-Duverger E; Shen CY; Yu JC; Wu PE; Hou MF; Andrulis IL; Selander T; Glendon G; Mulligan AM; Anton-Culver H; Ziogas A; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Jones M; Orr N; Ashworth A; Swerdlow A; Severi G; Baglietto L; Giles G; Southey M; Marmé F; Schneeweiss A; Sohn C; Burwinkel B; Yesilyurt BT; Neven P; Paridaens R; Wildiers H; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schott S; Bartram CR; Schmutzler RK; Cox A; Brock IW; Elliott G; Cross SS; Fasching PA; Schulz-Wendtland R; Ekici AB; Beckmann MW; Fletcher O; Johnson N; Silva Idos S; Peto J; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Dörk T; Schürmann P; Bremer M; Hillemanns P; Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Khusnutdinova E; Bermisheva M; Prokofieva D; Gancev S; Jakubowska A; Lubinski J; Jaworska K; Durda K; Nordestgaard BG; Bojesen SE; Lanng C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Radice P; Peterlongo P; Manoukian S; Bernard L; Couch FJ; Olson JE; Wang X; Fredericksen Z; Alnaes GG; Kristensen V; Børresen-Dale AL; Devilee P; Tollenaar RA; Seynaeve CM; Hooning MJ; García-Closas M; Chanock SJ; Lissowska J; Sherman ME; Hall P; Liu J; Czene K; Kang D; Yoo KY; Noh DY; Lindblom A; Margolin S; Dunning AM; Pharoah PD; Easton DF; Guénel P; Brauch H
    Hum Mutat; 2012 Jul; 33(7):1123-32. PubMed ID: 22461340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.
    Kriege M; Jager A; Hooning MJ; Huijskens E; Blom J; van Deurzen CH; Bontenbal M; Collee JM; Menke-Pluijmers MB; Martens JW; Seynaeve C
    Cancer; 2012 Feb; 118(4):899-907. PubMed ID: 21761396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non-carriers.
    Zhang Y; Huang M; Zhu Z
    Mol Biol Rep; 2012 Jun; 39(6):6881-6. PubMed ID: 22307791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China.
    He X; Yao G; Li F; Li M; Yang X
    Int J Mol Sci; 2014 Jan; 15(2):2130-41. PubMed ID: 24481062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer.
    Phuah SY; Looi LM; Hassan N; Rhodes A; Dean S; Taib NA; Yip CH; Teo SH
    Breast Cancer Res; 2012 Nov; 14(6):R142. PubMed ID: 23116406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and pathologic characteristics of breast cancer patients carrying the c.3481_3491del11 mutation.
    El Tannouri R; Albuisson E; Jonveaux P; Luporsi E
    Fam Cancer; 2019 Jan; 18(1):1-8. PubMed ID: 29550896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.
    Young SR; Pilarski RT; Donenberg T; Shapiro C; Hammond LS; Miller J; Brooks KA; Cohen S; Tenenholz B; Desai D; Zandvakili I; Royer R; Li S; Narod SA
    BMC Cancer; 2009 Mar; 9():86. PubMed ID: 19298662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
    Hamdi Y; Soucy P; Kuchenbaeker KB; Pastinen T; Droit A; Lemaçon A; Adlard J; Aittomäki K; Andrulis IL; Arason A; Arnold N; Arun BK; Azzollini J; Bane A; Barjhoux L; Barrowdale D; Benitez J; Berthet P; Blok MJ; Bobolis K; Bonadona V; Bonanni B; Bradbury AR; Brewer C; Buecher B; Buys SS; Caligo MA; Chiquette J; Chung WK; Claes KB; Daly MB; Damiola F; Davidson R; De la Hoya M; De Leeneer K; Diez O; Ding YC; Dolcetti R; Domchek SM; Dorfling CM; Eccles D; Eeles R; Einbeigi Z; Ejlertsen B; ; Engel C; Gareth Evans D; Feliubadalo L; Foretova L; Fostira F; Foulkes WD; Fountzilas G; Friedman E; Frost D; Ganschow P; Ganz PA; Garber J; Gayther SA; ; Gerdes AM; Glendon G; Godwin AK; Goldgar DE; Greene MH; Gronwald J; Hahnen E; Hamann U; Hansen TV; Hart S; Hays JL; ; Hogervorst FB; Hulick PJ; Imyanitov EN; Isaacs C; Izatt L; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Joseph V; Just W; Kaczmarek K; Karlan BY; ; Kets CM; Kirk J; Kriege M; Laitman Y; Laurent M; Lazaro C; Leslie G; Lester J; Lesueur F; Liljegren A; Loman N; Loud JT; Manoukian S; Mariani M; Mazoyer S; McGuffog L; Meijers-Heijboer HE; Meindl A; Miller A; Montagna M; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Nussbaum RL; Olah E; Olopade OI; Ong KR; Oosterwijk JC; Osorio A; Papi L; Park SK; Pedersen IS; Peissel B; Segura PP; Peterlongo P; Phelan CM; Radice P; Rantala J; Rappaport-Fuerhauser C; Rennert G; Richardson A; Robson M; Rodriguez GC; Rookus MA; Schmutzler RK; Sevenet N; Shah PD; Singer CF; Slavin TP; Snape K; Sokolowska J; Sønderstrup IM; Southey M; Spurdle AB; Stadler Z; Stoppa-Lyonnet D; Sukiennicki G; Sutter C; Tan Y; Tea MK; Teixeira MR; Teulé A; Teo SH; Terry MB; Thomassen M; Tihomirova L; Tischkowitz M; Tognazzo S; Toland AE; Tung N; van den Ouweland AM; van der Luijt RB; van Engelen K; van Rensburg EJ; Varon-Mateeva R; Wappenschmidt B; Wijnen JT; Rebbeck T; Chenevix-Trench G; Offit K; Couch FJ; Nord S; Easton DF; Antoniou AC; Simard J
    Breast Cancer Res Treat; 2017 Jan; 161(1):117-134. PubMed ID: 27796716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
    Collins LC; Martyniak A; Kandel MJ; Stadler ZK; Masciari S; Miron A; Richardson AL; Schnitt SJ; Garber JE
    Am J Surg Pathol; 2009 Jul; 33(7):1093-7. PubMed ID: 19390427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
    Figueroa JD; Garcia-Closas M; Humphreys M; Platte R; Hopper JL; Southey MC; Apicella C; Hammet F; Schmidt MK; Broeks A; Tollenaar RA; Van't Veer LJ; Fasching PA; Beckmann MW; Ekici AB; Strick R; Peto J; dos Santos Silva I; Fletcher O; Johnson N; Sawyer E; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Bojesen S; Flyger H; Nordestgaard BG; Benítez J; Milne RL; Ignacio Arias J; Zamora MP; Brenner H; Müller H; Arndt V; Rahman N; Turnbull C; Seal S; Renwick A; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Hein R; Wang-Gohrke S; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov YI; Karstens JH; Bermisheva M; Prokofieva D; Gantcev SH; Khusnutdinova E; Lindblom A; Margolin S; Chenevix-Trench G; Beesley J; Chen X; ; Mannermaa A; Kosma VM; Soini Y; Kataja V; Lambrechts D; Yesilyurt BT; Chrisiaens MR; Peeters S; Radice P; Peterlongo P; Manoukian S; Barile M; Couch F; Lee AM; Diasio R; Wang X; Giles GG; Severi G; Baglietto L; Maclean C; Offit K; Robson M; Joseph V; Gaudet M; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis I; Knight JA; Mulligan AM; O'Malley FP; Brinton LA; Sherman ME; Lissowska J; Chanock SJ; Hooning M; Martens JW; van den Ouweland AM; Collée JM; Hall P; Czene K; Cox A; Brock IW; Reed MW; Cross SS; Pharoah P; Dunning AM; Kang D; Yoo KY; Noh DY; Ahn SH; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Ding SL; Hsu HM; Yu JC; Anton-Culver H; Ziogas A; Ashworth A; Swerdlow A; Jones M; Orr N; Trentham-Dietz A; Egan K; Newcomb P; Titus-Ernstoff L; Easton D; Spurdle AB
    Hum Mol Genet; 2011 Dec; 20(23):4693-706. PubMed ID: 21852249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study.
    Park HL; Ziogas A; Chang J; Desai B; Bessonova L; Garner C; Lee E; Neuhausen SL; Wang SS; Ma H; Clague J; Reynolds P; Lacey JV; Bernstein L; Anton-Culver H
    BMC Cancer; 2016 Jan; 16():14. PubMed ID: 26758508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study.
    Rashid MU; Muzaffar M; Khan FA; Kabisch M; Muhammad N; Faiz S; Loya A; Hamann U
    PLoS One; 2015; 10(10):e0141562. PubMed ID: 26517870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients.
    Hato Y; Kondo N; Yoshimoto N; Endo Y; Asano T; Dong Y; Nishimoto M; Takahashi S; Fujii Y; Nakanishi R; Toyama T
    Int J Clin Oncol; 2016 Jun; 21(3):539-47. PubMed ID: 26482374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Sinilnikova OM; Antoniou AC; Simard J; Healey S; Léoné M; Sinnett D; Spurdle AB; Beesley J; Chen X; ; Greene MH; Loud JT; Lejbkowicz F; Rennert G; Dishon S; Andrulis IL; ; Domchek SM; Nathanson KL; Manoukian S; Radice P; Konstantopoulou I; Blanco I; Laborde AL; Durán M; Osorio A; Benitez J; Hamann U; Hogervorst FB; van Os TA; Gille HJ; ; Peock S; Cook M; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Brewer C; ; Hughes DJ; Coupier I; Giraud S; Coulet F; Colas C; Soubrier F; Rouleau E; Bièche I; Lidereau R; Demange L; Nogues C; Lynch HT; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Sutter C; Deissler H; Schaefer D; Froster UG; ; Aittomäki K; Nevanlinna H; McGuffog L; Easton DF; Chenevix-Trench G; Stoppa-Lyonnet D;
    Br J Cancer; 2009 Oct; 101(8):1456-60. PubMed ID: 19707196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
    Silvestri V; Barrowdale D; Mulligan AM; Neuhausen SL; Fox S; Karlan BY; Mitchell G; James P; Thull DL; Zorn KK; Carter NJ; Nathanson KL; Domchek SM; Rebbeck TR; Ramus SJ; Nussbaum RL; Olopade OI; Rantala J; Yoon SY; Caligo MA; Spugnesi L; Bojesen A; Pedersen IS; Thomassen M; Jensen UB; Toland AE; Senter L; Andrulis IL; Glendon G; Hulick PJ; Imyanitov EN; Greene MH; Mai PL; Singer CF; Rappaport-Fuerhauser C; Kramer G; Vijai J; Offit K; Robson M; Lincoln A; Jacobs L; Machackova E; Foretova L; Navratilova M; Vasickova P; Couch FJ; Hallberg E; Ruddy KJ; Sharma P; Kim SW; ; Teixeira MR; Pinto P; Montagna M; Matricardi L; Arason A; Johannsson OT; Barkardottir RB; Jakubowska A; Lubinski J; Izquierdo A; Pujana MA; Balmaña J; Diez O; Ivady G; Papp J; Olah E; Kwong A; ; Nevanlinna H; Aittomäki K; Perez Segura P; Caldes T; Van Maerken T; Poppe B; Claes KB; Isaacs C; Elan C; Lasset C; Stoppa-Lyonnet D; Barjhoux L; Belotti M; Meindl A; Gehrig A; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Kast K; Arnold N; Varon-Mateeva R; Wand D; Godwin AK; Evans DG; Frost D; Perkins J; Adlard J; Izatt L; Platte R; Eeles R; Ellis S; ; Hamann U; Garber J; Fostira F; Fountzilas G; Pasini B; Giannini G; Rizzolo P; Russo A; Cortesi L; Papi L; Varesco L; Palli D; Zanna I; Savarese A; Radice P; Manoukian S; Peissel B; Barile M; Bonanni B; Viel A; Pensotti V; Tommasi S; Peterlongo P; Weitzel JN; Osorio A; Benitez J; McGuffog L; Healey S; Gerdes AM; Ejlertsen B; Hansen TV; Steele L; Ding YC; Tung N; Janavicius R; Goldgar DE; Buys SS; Daly MB; Bane A; Terry MB; John EM; Southey M; Easton DF; Chenevix-Trench G; Antoniou AC; Ottini L
    Breast Cancer Res; 2016 Feb; 18(1):15. PubMed ID: 26857456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.